![Katherine Stueland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 7 M $ al 31/07/2026
Currently, Katherine A. Stueland is Chief Executive Officer & Director at GeneDx Holdings Corp.
starting in 2026, President & Chief Executive Officer at GeneDx LLC since 2021, Director at Cancan Health, and President & Director at Sema4 OpCo, Inc. Formerly, Ms. Stueland was President & Chief Executive Officer at GeneDx, Inc., Director at Rivkin Center for Ovarian Cancer, VP-Corporate Communications & Investor Relations at Dendreon Corp.
from 2011 to 2012, Principal at Vivo Communications, LLC in 2013, and Chief Commercial Officer at Invitae Corp.
from 2016 to 2021.
Education includes an undergraduate degree from Miami University, conferred in 1997.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/06/2026 | 104.372 ( 0,35 % ) | 7 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENEDX HOLDINGS CORP. | Director Ejecutivo | 29/04/2022 |
Cancan Health | Director/Miembro de la Junta | - |
GeneDx LLC
 GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services | Director Ejecutivo | 01/06/2021 |
Mount Sinai Genomics, Inc.
 Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
| INVITAE CORPORATION | Contacto de Relaciones con Inversores | 01/10/2016 |
Vivo Communications, LLC
 Vivo Communications, LLC Specialty TelecommunicationsCommunications Provides telecommunication services | Corporate Officer/Principal | 01/12/2013 |
| DENDREON CORPORATION | Contacto de Relaciones con Inversores | 01/06/2012 |
GeneDx, Inc.
 GeneDx, Inc. Medical/Nursing ServicesHealth Services Performs genetic testing for rare hereditary disorders | Director Ejecutivo | - |
Rivkin Center for Ovarian Cancer
 Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Provides funds for ovarian cancer researchers | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Invitae Corp.
 Invitae Corp. Medical/Nursing ServicesHealth Services Provides genetic testing services for patients | Health Services |
Miami University
 Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeneDx, Inc.
GeneDx, Inc. Medical/Nursing ServicesHealth Services Performs genetic testing for rare hereditary disorders | Health Services |
Rivkin Center for Ovarian Cancer
Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Provides funds for ovarian cancer researchers | Commercial Services |
Cancan Health | |
Vivo Communications, LLC
Vivo Communications, LLC Specialty TelecommunicationsCommunications Provides telecommunication services | Communications |
Mount Sinai Genomics, Inc.
Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases | Health Services |
GeneDx Holdings Corp.
 GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services | Health Services |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services | Health Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
